/
Controversies in HRT C.R.Kannan Controversies in HRT C.R.Kannan

Controversies in HRT C.R.Kannan - PowerPoint Presentation

majerepr
majerepr . @majerepr
Follow
342 views
Uploaded On 2020-06-16

Controversies in HRT C.R.Kannan - PPT Presentation

MD Professor of Medicine UNSOM Las Vegas In several cross sectional studies Women taking HRT after menopause appeared to have Less CAD Less Fractures Premarin became the best selling drug in ID: 779509

hormones estrogen women bioidentical estrogen hormones bioidentical women hormone ert trial estradiol whi myth bioactive vte breast synthetic hrt

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "Controversies in HRT C.R.Kannan" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Controversies in HRT

C.R.Kannan

, M.D.

Professor of Medicine

UNSOM, Las Vegas

Slide2

In several cross sectional studies…..

Women taking HRT

after

menopause appeared to have

Less CAD

Less Fractures

Premarin

became the best selling drug in

U.S.History

with

FDA

approval

despite little

or no data on

randomized trials

Slide3

Women’s Health Initiative (WHI)

1992

2007

HRT

ERT

versus

Placebo

27,500

What are the protective

effects of HRT in

healthy women

with no obvious disease?

First randomised trial

Slide4

Summary

Use of Estrogen Plus Progesterone

in

healthy

women for prevention…….

CAD 29%

Stroke 41%VTE 111%Breast ca 26

%

Colo-

Rectal ca 37%

Hip Fracture 34%

Vert fracture 34%

WHI data: the bone protection is

NOT worth

the

risks. Study was terminated before completion

Slide5

Summary

Use of Estrogen

alone

in healthy

women for prevention…….

Stroke VTE BUT NOT Breast

ca

Hip

Fracture

Vert

fracture

WHI data: the bone protection is NOT

worth the other risks

Slide6

Criticisms

of the

WHI trial

Is this truly a primary prevention trial?

Would the same CV risk be applicable

if started earlier?

What about other routes of administration?

Can these data be applied to patients taking Estrogen only?

Slide7

Can these data be applied to patients taking Estrogen (CEE) only?

Anderson et al JAMA 2004

CHD

CVA

VTE

Breast

CA

Hip

Fract

Slight

increase

NSS

39%

33%

23%

Slight

decrease

NSS

39%

Slide8

Even though ERT provides

Bone Protection This Rx is not worth the risk

Many women are coming off ERT

Slide9

Even though ERT provides

Bone Protection This Rx is not worth the risk

Many women

came off

ERT

Slide10

In 2001 WHI stopped the E+P trial

In 2004 WHI stopped then Estrogen only trial

Many women

came off

ERT

WHI changed practice

ERT prescriptions fell by 70% in 07

Short term use for vasomotor

Sx

Transdermal

HT doubled

vs

PO

Slide11

Long awaited

KEEPS trial

Healthy women 42-58 years old within 3 years

of final menses at time of

randomisation

Double blind RCT

727 women

Low dose

oral Estrogen

Trans Dermal

Estrogen

Cyclic monthly

Progesterone

Placebo

O-CEE

Premarin

0.45 mg

Trans Dermal

Estrogen

Climara

50 mcg day

Cyclic monthly

Prometrium

200 mg/d x 12 days

Slide12

KEEPS

trial Results

Presented in the

North American Menopause Society in October 2012

Relieved vasomotor

symptoms

Neutral effects on BP

Lowered LDL, Increased HDL

and TG

O-CEE

Premarin

0.45 mg

Trans Dermal

Estrogen

Climara

50 mcg day

Neutral effect on

LDL HDL, TG

Increased Insulin sensitivity

Improved Sexual function

Libido, Arousal

Lubrication

And Orgasm

Slide13

Long awaited

KEEPS trial Results

Presented in the

North American Menopause Society in October 2012

No significant RISKS

or BENEFITS regarding

Breast cancer Uterine cancer MI or Stroke VTE

Atherosclerosis

progression

O-CEE

Premarin

0.45 mg

Trans Dermal

Estrogen

Climera

50 mcg day

Study not sufficiently powered to determine risks or benefits on clinical events

Slide14

Summary

Short term Rx with

lowest dose estrogen is safe ,

relieves vasomotor

sx

and improves QOL

Remains to be seen

if long term HRT is harmful

when started

early.

As it stands, long term HRT is

not indicated for

prevention of disease

(USPSTF Oct 12, 2012)

ERT is contraindicated in….

Hx

of Breast Cancer

Endometrial Cancer

Strong Family

Hx

of above

Established Heart disease

VTE

?Gall bladder disease

Nicotine abuse

Slide15

“I want natural

hormones!”

“Prescription estrogens are not

identical to what my body makes!”

Bioidentical

hormones are safer than those made by the industry! ”

“I want my estrogens customized

to my body’s needs!”

“ Test my saliva and customize my hormone replacement!

“ I do not want to take a pill made from horse’s urine!!

Slide16

What are

Bioidentical Hormones?

Slide17

Definition of terms

Bioidentical

Hormones

Hormones identical in

hormone structure to

endogenous hormones

Synthetic

Synthetic hormones

e.g.

premarin

Customized

Compounded

Formulations

Tailor made, customized

To the individual.

Slide18

Myth 1

Bioidentical

hormones and

Synthetic hormones are polar opposites.”

Slide19

Bioidentical

hormones are also synthetic

Synthetic hormones are also

bioidentical

.

Tri est

Bi-est

Chemically Extracting

diosgenin

from

Plants (yams and soy)

17

β

-

estradiol

The prototypical estrogen

most identical to endogenously

produced hormone is synthesized

And available as brand

e.g

Estrace

Slide20

Bioidentical

hormones are also synthetic

Synththetic

hormones are also

bioidentical.

Tri

estBi-est

Chemically Extracting

diosgenin

from

Plants (yams and soy

17

β

-

estradiol

In fact, the most

bioidentical

estrogen is branded, prescription-regulated and FDA approved

Origin of this concept of

Bioidentical

hormones?

Slide21

Womens

’ Health Initiative 2001

Use of Estrogen Plus Progesterone

in healthy women carries a risk.

CAD 29%

Stroke 41%

VTE 111%Breast ca 2

6

%

Women came off estrogen.

Other “safer” and “natural”

alternatives were sought .

celebrities got into the act

Spawning a whole new industry.

Slide22

Prescription

Regulated

Bioidentical

Customized

Compounded

Bioidenticals

Chemical IdentityTo human hormones

Yes

Yes

FDA oversight

Yes No

Published Research

Yes minimal to none

Dose

Reproducibilty

Exact Inexact , inconsistent

Proven efficacy

Yes No RCT

Slide23

Myth 2

“I want natural hormones”

Nature

E2

17

β

Estradiol

Most bioactive estrogen

Produced by dominant follicle

E1

Estrone

Second Most bioactive estrogen.

Derived from E2 and Androgens

E3

Estriol

Least bioactive, derived from E2

Slide24

How natural are

bioidenticals?

Tri

est

Bi-

est

Compounded hormone

80 %

Estriol

10%

Estrone

10%

Estradiol

Compounded hormone

Estriol

:

Estradiol

8:1 or 9:1

How natural can it be when it has very little of

Estradiol

, the most bioactive estrogen?

Slide25

Myth 2

“I want natural hormones”

Truth

So called

Bioidenticals

Contain very little bioactive

Estrogen!

Slide26

Myth 3

“Prescription estrogens are not

Bio identical”

Truth

There are at least 23 products

that are FDA tested and

approved with hormones

identical to

Endogenous estrogen

Slide27

Oral

Estrace

0.5, 1 and 2 mg

Dermal

Climara 0.025 to 0.1 mg

Vivelle

0.025 to 0.1 mg

Alora

Dermal

Estraderm 0.05 to 0.1 mg

gel

Estragel

0.035

Local

Vaginal cream and ring

17

β

Estradiol

Progesterone

Prometrium

100 to 200 mg

Slide28

Myth 4

Bioidentical

hormones are safer than those made by the industry ”

Truth

There are no RCT that have proven that the compounded

bioidenticals

are safer.

Slide29

Myth 5

“Customized

bioidentcal

hormone therapy provides better results because it is individualized”

Truth

There are only half a dozen variations available. This is hardly sufficient for ‘individualization’

Slide30

Myth 6

“Customized

bioidentcal

hormone therapy can be provided by testing saliva for hormones ”

Truth

Salivary testing is not a

relaible

means of assessing the hormonal status.

Slide31

Bioidentical

hormone therapy

Represents unchartered waters.

There are alternatives that have been

Tested and provide the best replacement with the most bioactive

Ingredients.